<--- Back to Details
First PageDocument Content
Clinical pharmacology / Morphine / Opioids / Pharmaceuticals policy / Morphinans / Medical prescription / Prescription drug / Drug Enforcement Administration / Drug overdose / Pharmacy / Heroin
Date: 2016-03-07 15:08:17
Clinical pharmacology
Morphine
Opioids
Pharmaceuticals policy
Morphinans
Medical prescription
Prescription drug
Drug Enforcement Administration
Drug overdose
Pharmacy
Heroin

Letter to Governor Walker regarding CSAC

Add to Reading List

Source URL: law.alaska.gov

Download Document from Source Website

File Size: 292,91 KB

Share Document on Facebook

Similar Documents

RTT / Health / Medicine / Chemistry / Euphoriants / Morphine / Drug culture / Substance abuse / Opioid / Heroin / Harm reduction / Addiction

Microsoft Word - EO 21 Establishing The Governors Advisory Commission On Opioids And Addiction.docx

DocID: 1xU2W - View Document

HEROIN, FENTANYL & OTHER OPIOIDS A Comprehensive Resource for Families with a Teen or Young Adult

DocID: 1vp68 - View Document

Opioid Important Safety Information ABUSE POTENTIAL AND RISK OF LIFE­THREATENING RESPIRATORY DEPRESSION Extended­Release and Long­Acting (ER/LA) prescription opioid analgesics are opioids and Schedule II or Schedule I

DocID: 1viXO - View Document

CONSIDERATIONS FOR CLINICIANS WHEN CO-PRESCRIBING BENZODIAZEPINES AND OPIOIDS

DocID: 1v8TB - View Document

Ohio Guidelines for Prescribing Opioids for the Treatment of Chronic, Non-Terminal Pain 80 mg of a Morphine Equivalent Daily Dose (MED) “Trigger Point” Preface: These guidelines address the use of opioids for the tre

DocID: 1uYDS - View Document